Hopkinton, MA, United States of America

James Thomson Loch, Iii

This inventor holds 1 USPTO granted patent. Top assignee: E-Therapeutics Plc. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Thomson Loch, Iii. Retrieved from https://idiyas.com/inventor/james-thomson-loch-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James Thomson Loch, III: Innovator in Cannabinoid Compounds

Introduction

James Thomson Loch, III is an accomplished inventor based in Hopkinton, MA (US). He has made significant contributions to the field of cannabinoid compounds, showcasing his expertise through his innovative patent.

Latest Patents

James holds a patent for a "Process for the preparation of 3-substituted cannabinoid compounds." This patent describes a method of preparing a compound of formula I, including its optical isomers. The method involves oxidizing verbenone and its optical isomers, with R being hydrogen or a protecting group.

Career Highlights

James is currently associated with E-Therapeutics Plc, where he applies his knowledge and skills in cannabinoid research. His work has the potential to impact various applications in the pharmaceutical industry.

Collaborations

James collaborates with Nicholas John Holman, contributing to advancements in their field through shared expertise and innovative ideas.

Conclusion

James Thomson Loch, III is a notable inventor whose work in cannabinoid compounds exemplifies innovation in the pharmaceutical sector. His contributions are paving the way for future developments in this important area of research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…